Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis-A review

Psychoneuroendocrinology

Volumn 32, Issue 6, 2007, Pages 604-618

  Heesen, C ^a   Gold, S M ^b   Huitinga, I ^c   Reul, J M H M ^d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Autonomous nervous system; Experimental autoimmune encephalomyelitis; Experimental stress; Hypothalamic pituitary adrenal axis; Multiple sclerosis

Indexed keywords

AUTOANTIBODY; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DEXAMETHASONE; GADOLINIUM; GLUCOCORTICOID; INTERLEUKIN 1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; BRAIN ATROPHY; CHRONIC DISEASE; COGNITION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DEPRESSION; DISABILITY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FATIGUE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; MULTIPLE SCLEROSIS; NEGATIVE FEEDBACK; NEUROIMAGING; NEWBORN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; RAT; RELAPSE; REVIEW; STRESS;

ANIMALS; BEHAVIOR, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FETAL DEVELOPMENT; GLUCOCORTICOIDS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MULTIPLE SCLEROSIS; PITUITARY-ADRENAL SYSTEM; STRESS; TIME FACTORS;

EID: 34347393924     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2007.05.002     Document Type: Review

References (101)

1. Ackerman K.D., Martino M., Heyman R., Moyna N.M., and Rabin B.S. Immunologic response to acute psychological stress in MS patients and controls. J. Neuroimmunol. 68 (1996) 85-94
2. Ackerman K.D., Martino M., Heyman R., Moyna N.M., and Rabin B.S. Stressorinduced alteration of cytokine production in multiple sclerosis patients and controls. Psychosom. Med. 60 (1998) 484-491
3. Bakker J.M., Kavelaars A., Kamphuis P.J., Cobelens P.M., van Vugt H.H., van Bel F., and Heijnen C.J. Neonatal dexamethasone treatment increases susceptibility to experimental autoimmune disease in adult rats. J. Immunol. 165 10 (2000) 5932-5937
4. Ben-Nun A., Eisenstein S., and Cohen I.R. Experimental allergic ancephalomyelitis (EAE) in genetically resistant rats: PVG rats resist active induction of EAE but are susceptible to and can generate EAE effector T cell lines. J. Immunol. 129 (1982) 918-919
5. Benou C., Wang Y., Imitola J., Van Vlerken L., Chandras C., Karalis K.P., and Khoury S.J. Corticotroping-releasing hormone contributes to the peripheral inflammatory response in experimental autoimmune encephalomyelitis. J. Immunol. 174 (2005) 5407-5413
6. Bernard C.C.A., Gragcic E., and Singer G. The effect of stress, corticosterone and adrenalectomy on the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 17 (1988) 254
7. Bilang-Bleuel A., Ulbricht S., Chandramohan Y., De Carli S., Droste S.K., and Reul J.M.H.M. Psychological stress increases histone H3 phosphorylation in adult dentate gyrus granule neurons: involvement in a glucocorticoid receptor-dependent behavioural response. Eur. J. Neurosci. 22 7 (2005) 1691-1700
8. Bolton C., and Flower R.J. The effect of anti-glukokortikoid R U 38486 on steroidmediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat. Life Sci. 45 (1989) 97-104
9. Brown R.F., Tennant C.C., Sharrock M., Hodgkinson S., Dunn S.M., and Pollard J.D. Relationship between stress and relapse in multiple sclerosis: Part II. Direct and indirect relationships. Mult. Scler. 12 4 (2006) 465-475
10. Bukilica M., Sladjana D., Maric I., Dimitrijevic M., Markovic B.M., and Jankovic B.D. Stress-induced suppression of experimental allergic encephalomyelitis in the rat. Int. J. Neurosci. 59 (1991) 167-175
11. Campbell T., Meagher M.W., Sieve A., Scott B., Storts R., Welsh T.H., and Welsh C.J. The effects of restraint stress on the neuropathogenesis of Theiler's virus infection: I. Acute disease. Brain Behav. Immun. 15 3 (2001) 235-254
12. Chandler N., Jacobson S., Esposito P., Connolly R., and Theoharides T.C. Acute stress shortens the time to onset of experimental allergic encephalomyelitis in SJL/J mice. Brain Behav. Immun. 16 6 (2002) 757-763
13. Charcot J.M. Lectures on Diseases on the Nervous System (G. Sigerson, Trans.) (1877), New Sydenham Society, London
14. Chowdrey H.S., Larsen P.J., Harbuz M.S., Jessop D.S., Aguilera G., Eckland G., and Lightman S.L. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Br. J. Pharmacol. 116 5 (1995) 2417-2424
15. Correa S.G., Rodriguez-Galâan M.C., Rivero V.E., and Riera C.M. Chronic varied stress modulates experimental autoimmune encephalomyelitis in Wistar rats. Brain Behav. Immun. 12 (1998) 134-148
16. De Kloet E.R., and Reul J.M.H.M. Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems. Psychoneuroendocrinology 12 2 (1987) 83-105
17. De Kloet E.R., and DeRijk R. Signaling pathways in brain involved in predisposition and pathogenesis of stress-related disease: genetic and kinetic factors affecting the MR/GR balance. Ann. NY Acad. Sci. 1032 (2004) 14-34
18. De Kloet E.R., Vreugdenhil E., Oitzl M.S., and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19 3 (1998) 269-301
19. DeRijk R.H., Eskandari F., and Sternberg E.M. Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production. J. Neuroimmunol. 151 1-2 (2004) 180-188
20. Del Rey A., Klusman I., and Besedovsky H.O. Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1. Am. J. Physiol. 275 (1998) R1146-R1151
21. Dimitrijevic M., Laban O., von Hoersten S., Markovic B.M., and Jankovic B.D. Neonatal sound stress and development of experimental allergic encephalomyelitis in Lewis and DA rats. Int. J. Neurosci. 78 1-2 (1994) 135-143
22. Dowdell K.C., Gienapp I.E., Stuckman S., Wardrop R.M., and Whitacre C.C. Neuroendocrine modulation of chronic relapsing experimental autoimmune encephalomyelitis: a critical role for the hypothalamic-pituitary-adrenal axis. J. Neuroimmunol. 100 (1999) 243-251
23. Erkut Z.A., Hofman M.A., Ravid R., and Swaab D.F. Increased activity of hypothalamic cortcotropin-releasing hormone neurons in multiple Sclerosis. J. Neuroimmunol. 62 (1995) 27-33
24. Erkut Z.A., Endert E., Huitinga I., and Swaab D.F. Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis. Mult. Scler. 8 3 (2002) 229-236
25. Fassbender K., Schmidt R., Mossner R., Kischka U., Kuhnen J., Schwartz A., and Hennerici M. Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch. Neurol. 55 (1998) 66-72
26. Gasser D.L., Palm J., and Gonatas N.K. Genetic control of susceptibility to experimental allergic encephalomyelitis and the Ag-B locus of rats. J. Immunol. 115 2 (1975) 431-433
27. Gold S.M., Mohr D.C., Huitinga I., Flachenecker P., Sternberg E.M., and Heesen C. The role of stress-response systems for the pathogenesis and progression of multiple sclerosis. Trends Immunol 6 (2005) 644-651
28. Gold S.M., Raji A., Huitinga I., Wiedemann K., Schulz K..H., and Heesen C. Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis. J. Neuroimmunol. 165 1-2 (2005) 186-191
29. Goodin D.S., Ebers G.C., Johnson K.P., Rodriguez M., Sibley W.A., and Wolinsky J.S. The relationship of MS to physical trauma and psychological stress: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 52 (1999) 1737-1745
30. Gottschalk M., Kumpfel T., Flachenecker P., Uhr M., Trenkwalder C., Holsboer F., and Weber F. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch. Neurol. 62 2 (2005) 277-280
31. Grasser A., Moller A., Backmund H., Yassouridis A., and Holsboer F. Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis. Exp. Clin. Endocrinol. Diabetes 104 1 (1996) 31-37
32. Griffin A.C., and Whitacre C.C. Differential effects of stress on disease outcome in experimental allergic encephalomyelitis. FASEB J. 4 (1990) 254
33. Griffin A.C., Wolny A.C., and Whitacre C.C. Suppression of experimental autoimmune encephalomyelitis by restraint stress: sex differences. J. Neuroimmunol. 44 (1993) 103-116
34. Harbuz M.S., Leonard J.P., Lightman S.L., and Cuzner M.L. Changes in hypothalamic corticotrophin-releasing factor and anterior pituitary propiomelanocortin mRNA during the course of experimental allergic encephalomyelitis. J Neuroimmunol. 45 1-2 (1993) 127-132
35. Hemmer B., Archelos J.J., and Hartung H.P. New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3 4 (2002) 291-301
36. Heesen C., Schulz H., Schmidt M., Gold S.M., Tessmer W., and Schulz K.H. Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav. Immun. 16 (2002) 282-287
37. Heesen C., Gold S.M., Raji A., Schulz K.H., and Wiedemann K. Cognitive impairment correlates with hypothalamo-pitiuitary-adrenal axis dysregulation in multiple sclerosis. Psychoneuroendocrinology 27 (2002) 505-517
38. Heesen C., Gold S.M., Hartmann S., Mladek M., Reer R., Braumann K.M., Wiedemann K., and Schulz K.H. Endocrine and cytokine responses to standardized physical stress in multiple sclerosis. Brain Behav. Immun. 17 (2003) 473-481
39. Heesen C., Koehler G., Gross R., Tessmer W., Schulz K.H., and Gold S.M. Fatigue in multiple sclerosis: altered cardiovascular and cytokine responses to cognitive stress. Mult. Scler. 11 (2005) 51-57
40. Heesen C., Nawrath L., Reich C., Bauer N., Schulz K.H., and Gold S.M. Fatigue in multiple sclerosis-an example of cytokine mediated sickness-behavior. J. Neurol. Neurosurg. Psych. 77 1 (2006) 34-39
41. Hughes R.A.R.C., and Stedronska J. The susceptibility of rat strains to experimental allergic encephalomyelitis. Immunology 24 (1973) 879-884
42. Huitinga I., Schmidt E.D., Van der Cammen M.J.F., Binnekade R., and Tilders F.J.H. Priming with interleukin-1β suppresses experimental allergic encephalomyelitis in the Lewis rat. J. Neuroendocrinol. 12 (2000) 1186-1193
43. Huitinga I., Erkut Z.A., van Beurden D., and Swaab D.F. Impaired hypothalamuspituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann. Neurol. 55 (2004) 37-45
44. Jacobs R., Pawlak C.R., Mikeska E., Meyer-Olson D., Martin M., Heijnen C.J., Schewdlowski C.J., and Schmidt R.E. Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure. Rheumatology 40 (2001) 868-875
45. Johnson R.R., Storts R., Welsh Jr T.H., Welsh C.J., and Meagher M.W. Social stress alters the severity of acute Theiler's virus infection. J. Neuroimmunol. 148 1-2 (2004) 74-85
46. Kavelaars A., Heijnen C.J., Tennekes R., Bruggink J.E., and Koolhaas J.M. Individual behavioral characteristics of wild-type rats predict susceptibility to experimental autoimmune encephalomyelitis. Brain Behav. Immun. 13 4 (1999) 279-286
47. Karalis K., Muglia L.J., Bae D., Hildebrand H., and Majzoub J.A. CRH and the immune system. J. Neuroimmunol. 72 (1997) 131-136
48. Kuroda Y., Mori T., and Hori T. Restraint stress suppresses experimental allergic encephalomyelitis in Lewis rats. Brain Res. Bull. 34 1 (1994) 15-17
49. Laban O., Markovic B.M., Dimitrijevic M., and Jankovic B.D. Maternal deprivation and early weaning modulate experimental allergic encephalomyelitis in the rat. Brain Behav. Immun. 9 1 (1995) 9-19
50. Laban O., Dimitrijevic M., von Hoersten S., Markovic B.M., and Jankovic B.D. Experimental allergic encephalomyelitis in adult DA rats subjected to neonatal handling or gentling. Brain Res. 676 1 (1995) 133-140
51. Labeur M.S., Arzt E., Wiegers G.J., Holsboer F., and Reul J.M. Long-term intracerebroventricular corticotropin-releasing hormone administration induces distinct changes in rat splenocyte activation and cytokine expression. Endocrinology 136 6 (1995) 2678-2688
52. Lalive P.H., Burkhard P.R., and Chofflon M. TNF-alpha and psychologically stressful events in healthy subjects: potential relevance for multiple sclerosis relapse. Behav. Neurosci. 116 (2002) 1093-1097
53. Le Page C., Ferry A., and Rieu M. Effect of muscular exercise on chronic relapsing experimental autoimmune encephalomyelitis J. Appl. Physiol. 77 5 (1994) 2341-2347
54. Le Page C., Bourdoulous S., Beraud E., Couraud P.O., Rieu M., and Ferry A. Effect of physical exercise on adoptive experimental auto-immune encephalomyelitis in rats. Eur. J. Appl. Physiol. 73 (1996) 130-135
55. Levine S., and Saltzman A. Nonspecific stress prevents relapses of experimental allergic encephalomyelitis in rats. Brain Behav. Immun. 1 (1987) 336-341
56. Levine S., Strebel R., Wenk E., and Harman P. Suppression of experimental autoimmune encephalomyelitis by stress. Exp. Biol. Med. 109 (1962) 294-298
57. Levine S., Sowinski R., and Steinetz B. Effects of experimental allergic encephalomyelitis on thymus and adrenal: relation to remission and relapse. Proc. Soc. Exp. Biol. Med. 165 2 (1980) 218-224
58. Limone P., Ferrero B., Calvelli P., Del Rizzo P., Rota E., Berardi C., Barberis A.M., Isaia G.C., and Durelli L.H. Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment. Acta Neurol. Scand. 105 5 (2002) 372-377
59. Linthorst A.C.E., Flachskamm C., Hopkins S.J., Hoadley M.E., Labeur M.S., Holsboer F., and Reul J.M.H.M. Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge. J. Neurosci. 17 11 (1997) 4448-4460
60. Logothetis L., Mylonas I.A., Baloyannis S., Pashalidou N., Orologas A., Zafeiropoulos A., Kosta V., and Theoharides T.C. A pilot, open label, clinical trials using hydroxyzine in multiple sclerosis. Int. J. Immunopathol. Pharmacol. 18 (2005) 771-778
61. MacPhee I., Antoni F.A., and Mason D.W. Spontaneous recovery from rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 169 (1989) 431-445
62. Mason J.W., Hartley L.H., Kotchen T.A., Mougey E.H., Ricketts N.T., and Jones L.G. Plasma cortisol and norepinephrine responses in anticipation of muscular exercise. Psychosom. Med. 35 (1973) 406-414
63. Mason D., MacPhee I., and Antoni F. The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat. Immunolology 7 (1990) 1-5
64. McEwen B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 886 1-2 (2000) 172-189
65. Mi W., Belyavskyi M., Johnson R.R., Sieve A.N., Storts R., Meagher M.W., and Welsh C.J. Alterations in chemokine expression following Theiler's virus infection and restraint stress. J. Neuroimmunol. 151 1-2 (2004) 103-115
66. Michelson D., Stone L., Galliven E., Magiakou M.A., Chrousos G.P., Sternberg E.M., and Gold P.W. Multiple sclerosis is associated with alterations in hypothalamic-pituitaryaxis function. J. Clin. Endocrinol. Metab. 79 (1994) 848-853
67. Mohr D.C., Hart S.L., Julian L., Cox D., and Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. Br. Med. J. 328 7442 (2004) 731-735
68. Owhashi M., Shouzui Y., and Arita H. Stress down-regulates experimental allergic encephalomyelitis (EAE) but permits activation and localization of autoreactive V beta 8.2+ T cells. Int. J. Neurosci. 89 3-4 (1997) 177-188
69. Pedersen B., and Hoffman-Goetz L. Exercise and the immune system. Physiol. Rev. 80 (2000) 1055-1081
70. Purba J.S., Raadsheer F., Hofman M.A., Ravid R., Polman C.H., Kamphorst W., and Swaab D.F. Increased number of corticotropin releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis. Neuroendocrinology 62 (1995) 62-70
71. Reder A.T. Adrenal size is increased in multiple sclerosis. Arch. Neurol. 51 (1994) 151-154
72. Reder A.T., Lowy M.T., Meltzer H.Y., and Antel J.P. Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy. Neurology 37 (1987) 849-853
73. Reul J.M.H.M., and De Kloet E.R. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 6 (1985) 2505-2511
74. Reul J.M.H.M., Gesing A., Droste S., Stec I.S., Weber A., Bachmann C., Bilang- Bleuel A., Holsboer F., and Linthorst A.C. The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur. J. Pharmacol. 405 1-3 (2000) 235-249
75. Roozendaal B. Glucocorticoids and the regulation of memory consolidation. Psychoneuroendocrinology 25 (2000) 213-238
76. Schedlowski M., Hosch W., Oberbeck R., Benschop R.J., Jacobs R., Raab H.R., and Schmidt R.E. Catecholamines modulate human NK cell circulation and function via spleenindependent beta 2-adrenergic mechanisms. J. Immunol. 156 1 (1996) 93-99
77. Schluesener H.J., Sobel R.A., Linington C., and Weiner H.L.A. Monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139 12 (1987) 4016-4021
78. Schumann E.M., Kumpfel T., Then Bergh F., Trenkwalder C., Holsboer F., and Auer D.P. Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume. Ann. Neurol. 51 (2002) 763-767
79. Segerstrom S.C., and Miller G.E. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130 4 (2004) 601-630
80. Sieve A.N., Steelman A.J., Young C.R., Storts R., Welsh T.H., Welsh C.J., and Meagher M.W. Chronic restraint stress during early Theiler's virus infection exacerbates the subsequent demyelinating disease in SJL mice. J. Neuroimmunol. 155 1-2 (2004) 103-118
81. Selye H. The general adaptation syndrome and the diseases of adaptation. The J. Clin. Endocrinol. 6 (1946) 117-231
82. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23 (2005) 683-747
83. Stefferl A., Linington C., Holsboer F., and Reul J.M.H.M. Susceptibility and resistance to experimental allergic encephalomyelitis: relationship with hypothalamic-pituitaryadrenocortical axis responsiveness in the rat. Endocrinology 140 11 (1999) 4932-4938
84. Stefferl A., Storch M.K., Linington C., Stadelmann C., Lassmann H., Pohl T., Holsboer F., Tilders F.J., and Reul J.M.H.M. Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone. Endocrinology 142 8 (2001) 3616-3624
85. Steinman L., and Zamvil S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann. Neurol. 60 1 (2006) 12-21
86. Sternberg E.M., Young 3rd W.S., Bernardini R., Calogero A.E., Chrousos G.P., Gold P.W., and Wilder R.L. A central nervous system defect in biosynthesis of corticotropinreleasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc. Natl. Acad. Sci. 86 12 (1989) 4771-4775
87. Teunis M.A., Heijnen C.J., Sluyter F., Bakker J.M., Van Dam A.M., Hof M., Cools A.R., and Kavelaars A. Maternal deprivation of rat pups increases clinical symptoms of experimental autoimmune encephalomyelitis at adult age. J. Neuroimmunol. 133 1-2 (2002) 30-38
88. Then Bergh F., Kümpfel T., Trenkwalder C., Rupprecht R., and Holsboer F. Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course in multiple sclerosis. Neurology 53 (1999) 772-777
89. Then Bergh F., Grasser A., Trenkwalder C., Backmund H., Holsboer F., and Rupprecht R. Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis. J. Neurol. 246 4 (1999) 292-298
90. Theoharides T.C., and Cochrane D.E. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 146 (2004) 1-12
91. van Winsen L.M., Muris D.F., Polman C.H., Dijkstra C.D., van den Berg T.K., and Uitdehaag B.M. Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis. J. Clin. Endocrinol. Metab. 90 2 (2005) 734-740
92. van Winsen L.M., Hooper-van Veen T., van Rossum E.F., Polman C.H., van den Berg T.K., Koper J.W., and Uitdehaag B.M. The impact of glucocorticoid receptor gene polymorphisms on glucocorticoid sensitivity is outweighted in patients with multiple sclerosis. J. Neuroimmunol. 167 1-2 (2005) 150-156
93. Villas P.A., Dronsfield M.J., and Blankenhorn E.P. Experimental allergic encephalomyelitis and corticosterone studies in resistant and susceptible rat strains. Clin. Immunol. Immunopathol. 61 1 (1991) 29-40
94. Webster E.L., Torpy D.J., Elenkov I.J., and Chrousos G.P. Corticotropin-releasing hormone and inflammation. Ann. N. Y. Acad. Sci. 840 (1998) 21-32
95. Wei T., and Lightman S.L. The neuroendocrine axis in patients with multiple sclerosis. Brain 120 (1997) 1067-1076
96. Wei T., Knight R.A., and Lightman S.L. Mitogenic response and steroid sensitivity in MS lymphocytes. Acta Neurol. Scand. 96 1 (1997) 28-33
97. Wei R., Phillips T.M., and Sternberg E.M. Specific upregulation of CRH or AVP secretion by acetlycholine or lipopolysaccharide in inflammatory suceptible Leiws rat fetal hypothalamic cells. J. Neuroimmunol. 131 (2002) 31-40
98. Wekerle H., Kojima K., Lannes-Vieira J., Lassmann H., and Linington C. Animal models. Ann. Neurol. 36 (1994) S47-S53
99. Welsh C.C.R., Bustamante L., Nayak M., Welsh T.H., Dean D.D., and Meagher M.W. The effects of restraint stress on the neuropathogenesis of Theiler's virus infection: II. NK cell function and cytokine levels in acute disease. Brain Behav. Immun. 18 (2004) 166-174
100. Whitacre C.C., Dowdell K., and Griffin A.C. Neuroendocrine influences on experimental autoimmune encephalomyelitis. Ann. N. Y. Acad. Sci. 840 (1998) 705-716
101. Zapulla J.P., Arock M., Mars L.T., and Liblau R.S. Mast cells: new targets for multiple sclerosis therapy?. J. Neuroimmunol. 131 (2002) 5-20